Asia Pacific Parenteral Nutrition Market Size & Outlook
Asia Pacific parenteral nutrition market, 2018-2030 (US$M)
Related Markets
Asia Pacific parenteral nutrition market highlights
- The Asia Pacific parenteral nutrition market generated a revenue of USD 1,093.5 million in 2023.
- The market is expected to grow at a CAGR of 7.1% from 2024 to 2030.
- In terms of segment, oral was the largest revenue generating product in 2023.
- Oral is the most lucrative product segment registering the fastest growth during the forecast period.
- Country-wise, South Korea is expected to register the highest CAGR from 2024 to 2030.
Asia Pacific data book summary
| Market revenue in 2023 | USD 1,093.5 million |
| Market revenue in 2030 | USD 1,762.9 million |
| Growth rate | 7.1% (CAGR from 2023 to 2030) |
| Largest segment | Oral |
| Fastest growing segment | Oral |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Oral, Enteral |
| Key market players worldwide | Baxter International Inc, Allergan, Teva Pharmaceutical Industries Ltd, Otsuka Pharmaceutical, Grifols SA Ordinary Shares - Class A, B. Braun, CSL Ltd, Fresenius SE & Co KGaA, Pfizer Inc, Sichuan Kelun Pharmaceutical |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 15.4% of the global parenteral nutrition market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 1,762.9 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Parenteral Nutrition Market Scope
Parenteral Nutrition Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Asia Pacific parenteral nutrition market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to parenteral nutrition market will help companies and investors design strategic landscapes.
Oral was the largest segment with a revenue share of 86.95% in 2023. Horizon Databook has segmented the Asia Pacific parenteral nutrition market based on oral, enteral covering the revenue growth of each sub-segment from 2018 to 2030.
China and Japan majorly drive the Asia Pacific region’s economy. China dominated the overall market in terms of revenue share owing to high R&D expenditure by public & private entities in the research sector, technological advancements, and the high number of collaborations between various stakeholders, including the medical fraternity & universities.
The growing prevalence of chronic diseases due to unhealthy eating habits and rising demand for cost-effective care treatment are some of the factors expected to drive market growth.
Reasons to subscribe to Asia Pacific parenteral nutrition market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Asia Pacific parenteral nutrition market databook
-
Our clientele includes a mix of parenteral nutrition market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific parenteral nutrition market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific parenteral nutrition market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Asia Pacific parenteral nutrition market size, by country, 2018-2030 (US$M)
Asia Pacific Parenteral Nutrition Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
